Picture of Alkemy Capital Investments logo

ALK Alkemy Capital Investments News Story

0.000.00%
gb flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapMomentum Trap

REG - Alkemy Capital Invs. - Interim Results

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241002:nRSB5409Ga&default-theme=true

RNS Number : 5409G  Alkemy Capital Investments PLC  02 October 2024

 

 

 

Alkemy Capital Investments Plc

 

Interim Results for the Six Month Ended 31 July 2024

 

Alkemy Capital Investments plc ("Alkemy" or the "Company") announces its
unaudited financial statements for the 6 months ended 31 July 2024 ("Financial
Statements").

 

Chairman's Statement

I have great pleasure in presenting our interim results for the period ended
31 July 2024.

 

Since the inception of Alkemy, its wholly-owned subsidiary Tees Valley Lithium
(TVL) has made excellent progress in advancing its key lithium refinery
project in Teesside, receiving planning and environmental permissions,
securing feedstock and establishing other key strategic partnerships along
with key governmental, industry and media recognition, reflecting its
commitment to becoming a leader in the low-carbon production of battery-grade
lithium hydroxide.

 

Despite recent market shifts, European demand for lithium remains on an
unprecedented upward trajectory. As Europe's car makers make the switch to EVs
to meet this burgeoning demand there is over 700GW of gigafactory capacity
either in construction or planned to provide the batteries for these EVs.
These gigafactories will require over 650,000 tonnes of locally refined
lithium per year in the form of either hydroxide or carbonate depending on the
type of vehicle. Currently the UK and Europe has very limited lithium refining
capacity.

 

TVL's processing refinery in Teesside is expected to produce enough lithium
hydroxide to supply 100% of the forecasted automotive demand in the UK by
2030, with a further 35% of its total production available for export to other
countries in Europe and elsewhere.

TVL has reached an agreement in principle with international trading house
Wogen for the supply of technical grade lithium carbonate to TVL's merchant
refinery in Teesside. Wogen is a leading international trader of off-exchange
specialty metals and minerals, with a long history and well-established
presence in the battery metals market across Asia, the United States and
Europe. Wogen intends to supply up to 20,000 tonnes of technical grade lithium
carbonate feedstock per annum, for an initial period of five years. The supply
will be sufficient to fill the first of TVL's proposed four trains, producing
around 24,000 tonnes of battery grade lithium hydroxide or lithium carbonate
equivalent.

 

Having secured feedstock for its first train, TVL is now focussed on obtaining
initial mezzanine funding which will enable it to complete Front End
Engineering Design (FEED) and commence the purchase of key long lead items for
the refinery. TVL is currently making good progress in these discussions and
expects to make further announcements on this front in the short term.

 

Building on the successful foundations laid by TVL, Alkemy will continue to
explore new horizons in the battery minerals sector to encompass a range of
critical battery minerals, positioning it as a diversified leader in the
energy transition sector, however the immediate focus will remain on securing
funding for TVL.

 

During the period we have continued to make significant progress in a
challenging macro environment.

The pace to decarbonise however continues to accelerate and with a growing
need for lithium hydroxide and now a growing preference from western OEM's to
source lithium hydroxide using more local supply chains, Alkemy is well
positioned to benefit from these changes.

 

The support received from third parties including major OEMs provides
validation of our proposed lithium refining strategy. The rapid completion of
due diligence to the satisfaction of certain OEMs is testament to the quality
of the work undertaken by our commercial and technical teams and confirms our
wider business case.

 

We would like to take this opportunity to thank our shareholders for their
continued support and patience and look forward to reporting on our progress
during 2024 as we deliver on our strategy.

 

Paul Atherley

Non-Executive Chairman

 

2 October 2024

 

 

STATEMENT OF COMPREHENSIVE INCOME

for the period ended 31 July 2024

 

 

                                                                                                        For six months ended           For the six months ended 31 July 2023  Year ended 31 January 2024 (audited)

                                                                                                        31 July 2024 (unaudited)       (unaudited)
                                                                                                        £                              £                                      £
                                                                                              Note

 Other income                                                                                           -                              -                                      1,247
 Administrative expenses                                                                                (563,812)                      (947,423)                              (1,454,195)
 Project Development costs                                                                              (91,845)                       (215,461)                              (634,288)
 Business Development costs                                                                             -                              -                                      (1,852)
 Finance costs                                                                                          (22,059)                       -                                      (1,697)
 Foreign exchange gains / (losses)                                                                      667                            960                                    (5,215)
 Loss before taxation                                                                                   (677,049)                      (1,161,924)                            (2,096,000)

 Income tax                                                                                             -                              95,278                                 325,018
 Loss after taxation                                                                                    (677,049)                      (1,066,646)                            (1,770,982)
 Other Comprehensive income

 Exchange gains / (losses) on translation of foreign operations                                         (9,707)                        6,609                                  (2,306)
 Total other comprehensive income                                                                       (9,707)                        6,609                                  (2,306)
                                                                                                        (686,756)                      (1,060,037)                            (1,773,288)

 Total comprehensive loss

 for the year

 Earnings per share                                                                           9
 Basic and diluted (£ per share)                                                                        (7.7p)                                                                (23.4p)

                                                                                                                                       (14.8p)

 

The accompanying notes form an integral part of the financial information.

 

 

 

STATEMENT OF FINANCIAL POSITION

As at 31 July 2024

 

                                                       Note      At 31 July 2024 (unaudited)  At 31 July   2023 (unaudited)    At 31 January 2024 (audited)
                                                                 £                            £                                £
 ASSETS
 Non current assets

 Intangibles - Project development costs                         317,089                      302,499                          317,089
 Total Non current assets                                        317,089                      302,499                          317,089

 Current assets
 Trade and other receivables                           8         97,749                       392,298                          126,303
 Cash and cash equivalents                                       51,114                       40,307                           45,458
 Total current assets                                            148,863                      432,605                          171,761

 Total assets                                                    465,952                      735,104                          488,850

 EQUITY
 Equity Attributable to Owners of the company
 Share capital                                         10        176,297                      144,000                          176,297
 Share premium                                                   4,261,626                    2,413,243                        4,261,626
 Share based payments                                            377,791                      126,053                          259,771
 Foreign exchange reserve                                        (14,658)                     3,964                            (4,951)
 Share to issue reserve                                          -                            872,162                          -
 Retained earnings                                               (5,890,440)                  (4,509,055)                      (5,213,391)
 Total equity                                                    (1,089,384)                  (949,633)                        (520,648)

 LIABILITIES
 Current liabilities
 Trade and other payables                              11        1,101,997                    1,323,448                        907,209
 Borrowings                                                      453,339                      361,289                          102,289
 Total current liabilities                                       1,555,336                    1,684,737                        1,009,498

 TOTAL EQUITY AND LIABILITIES                                    465,952                      735,104                          488,850

 

 

This report was approved by the board and authorised for issue on 2 October
2024 and signed on its behalf by:

 

Paul Atherley

Non-Executive Chairman

 

The accompanying notes form an integral part of the financial information.

 

STATEMENT OF CHANGES IN EQUITY

for the year ended 31 July 2024
 

 

 

                                                                  Share capital  Share Premium  Share Based Payments  Shares to Issue Reserve  Foreign Exchange Reserve  Retained Earnings  Total
                                                                  £              £              £                     £                        £                         £                  £

 As at 1 February 2023                                            144,000        2,413,243        63,221              -                        (2,645)                   (3,442,409)        (824,590)

 Loss for the year                                                -              -              -                     -                        -                         (1,066,646)        (1,066,646)
 Foreign exchange losses on translation of overseas subsidiaries  -              -              -                     -                        6,609                     -                  6,609
 Total Comprehensive income                                       -              -              -                     -                        6,609                     (1,066,646)        (1,060,037)

 Transactions with owners:
 Issue of shares                                                  -              -              -                     -                        -                         -                  -
 Issue of options                                                 -              -              62,832                -                        -                         -                  62,832
 Shares to issue                                                  -              -              -                     872,162                  -                         -                  872,162
 Total transactions with owners                                   -              -              62,832                872,162                  -                         -                  934,994

 Balance at 31 July 2023                                          144,000        2,413,243      126,053               872,162                  3,694                     (4,509,055)        (949,633)

 

 

 

                                                                  Share capital  Share Premium  Share Based Payments  Shares to Issue Reserve  Foreign Exchange Reserve  Retained Earnings  Total
                                                                  £              £              £                     £                        £                         £                  £

 As at 1 February 2024                                            176,297        4,261,626         259,771            -                           (4,951)                (5,213,391)        (520,648)

 Loss for the year                                                -              -              -                     -                        -                         (677,049)          (677,049)
 Foreign exchange losses on translation of overseas subsidiaries  -              -              -                     -                        (9,707)                   -                  (9,707)
 Total Comprehensive income                                       -              -              -                     -                        (9,707)                   (677,049)          (686,756)
 Transactions with owners:
 Issue of options                                                 -              -              118,020               -                        -                         -                  118,020

 Total transactions with owners                                   -              -              118,020               -                        -                         -                  118,020

 Balance at 31 July 2024                                          176,297        4,261,626      377,791               -                        (14,658)                  (5,890,440)        (1,089,384)

 

 

The accompanying notes form an integral part of the financial information.

 

STATEMENT OF CASHFLOWS

for the period ended 31 July 2024

 

                                                                       Six months                 Six months                             Year ended 31 January 2024 (audited)

                                                                       ended                      ended

                                                                       31 July 2024 (unaudited)   31 July 2023 (unaudited)
                                                                       £                          £                              £

 Loss before tax                                                       (677,049)                  (1,066,646)                    (1,770,982)
 Adjusted for:
 Share based payments                                                  118,020                    62,832                         196,550
 Expenditure met directly by funding provider                          -                          35,000                         -
 Finance costs                                                         22,059                     -                              -
 (Increase)/decrease in receivables                                    28,554                     (180,173)                      85,822
 (Decrease)/Increase in trade creditors                                206,788                    301,853                        (132,662)
 Net cash used in operating activities                                 (301,628)                  (847,134)                      (1,621,272)

 Investing activities
 Payments for intangible assets                                        -                          (3,686)                        -
 Net cash outflow from investigating activities                        -                          (3,686)                        -

 Financing activities
 Repayment of Borrowings                                               -                          -                              (224,000)
 Funds received against shares to issue                                -                          872,162                        -
 Cash from issue of Ordinary shares                                    -                          -                              1,880,680
 Proceeds from short term borrowings                                   318,900                    -                              -
 Interest paid                                                         (1,909)                    -                              -
 Net cash from financing activities                                    316,991                    872,162                        1,656,680

 Net (decrease)/increase in cash and cash equivalents                  15,363                      21,342                        35,408

 

 Cash and cash equivalents at beginning of the year                                                                              12,356

                                                                       45,458                     12,356
 Effects of foreign exchange on cash balances                          (9,707)                    6,609                          (2,306)
 Cash and cash equivalents at end of the year                          51,114                     40,307                         45,458

 

The accompanying notes form an integral part of the financial information.

 

 

 

 

 

 

 

 

 

 

NOTES TO THE FINANCIAL INFORMATION

 

1.    GENERAL INFORMATION

 

The Company was incorporated on 21 January 2021 in England and Wales as a
public company, limited by shares and with Registered Number 13149164 under
the Companies Act 2006. On incorporation, the Company's name was Alkemy
Capital Plc. On 4 February 2021, the Company's name was changed to Alkemy
Capital Investments Plc. The Company's registered office address is 167-169
Great Portland Street, Fifth Floor, London W1W 5PF. On 25 February 2022 the
Company formed a wholly owned subsidiary called Tees Valley Lithium Limited, a
company seeking to establish a Lithium Hydroxide Monohydrate ("LHM")
processing facility in Teesside, UK.

 

The Company's objective is to establish a LHM processing plant at its chosen
site in Teesside, UK which will aim to initially produce LHM from lithium
feedstock from various sources, to be sold to the UK and European mobile
energy markets.

 

In August 2022 the Company announced plans to build a lithium sulphate
monohydrate plant at Port Hedland, Australia's largest export port located in
the Pilbara region of Western Australia, to feed TVL's LHM facility in
Teesside and in September 2022 the Company formed a wholly owned subsidiary
called Port Hedland Lithium Pty Ltd.

 

Other than the Directors, the Company has no employees.

 

The Directors who served during the period were Sam Quinn, Paul Atherley,
Helen Pein and Vikki Jeckell.

 

 

2.    ACCOUNTING POLICIES

 

Basis of preparation

The principal accounting policies adopted by the Company in the preparation of
the Company Financial Information are set out below.

 

The Company Financial Information has been presented in £, being the
functional currency of the Company.

 

The Company Financial Information has been prepared in accordance with IFRS,
including interpretations made by the International Financial Reporting
Interpretations Committee issued by the International Accounting Standards
Board. The standards have been applied consistently. The historical cost basis
of preparation has been used.

 

The preparation of the financial statements in conformity with IFRS requires
the use of certain critical accounting estimates. It also requires the
Directors to exercise their judgment in the process of applying the Company's
accounting policies.

 

In the opinion of the management, the interim unaudited financial information
includes all adjustments considered necessary for fair and consistent
presentation of this financial information. The interim unaudited financial
information should be read in conjunction with the Company's audited financial
statements and notes for the year ended 31 January 2024.

 

Standards and interpretations issued but not yet applied

 

A number of new standards and amendments to standards and interpretations have
been issued but are not yet effective and, in some cases, have not yet been
adopted by the UKEU. The Directors do not expect that the adoption of these
standards will have a material impact on the Company Financial Information.

 

 

 

 

Going Concern

 

As part of their assessment of going concern, the Directors have prepared cash
forecasts to determine the funding requirements of the business over the 18
months from the reporting date. Cash requirements over this period have been
projected in the range of a £2m minimum (decelerated project development
case) to £9m maximum (accelerated project development case) depending on the
level of technical project development work being undertaken, as determined by
funding availability.

As at the date of this report, the Directors are considering a variety of
funding options from numerous parties to consider the option best suited to
balancing the immediate cash flow needs of the business and desire to
accelerate the project development timeframe against the need to avoid
unnecessary dilution of the shareholders during a period of depressed equity
market prices.  Options ranging from:

·      project level debt or strategic equity which would provide
sufficient funding to accelerate the project development program over the
period of consideration, including the LHM refinery train 1 FEED study
alongside development of the Port Hedland LSM refinery and TVG graphite
projects, as well as general working capital requirements;

·      market equity placings to secure working capital funding needs
whilst project development funding opportunities continue to be assessed;

·      convertible lending facilities which may act as a hybrid of
working capital and project development funding, allowing progression of
project development at a less accelerated rate that would be the case under a
more substantial project lending facility;

·      any combination of the above.

 

As successful execution of one of the above fundraising options cannot be
assured, a material uncertainty exists which may cast significant doubt on the
ability of the Company and Group to continue as a going concern and realise
its assets and discharge its liabilities in the normal course of business.

However, the Board remains in detailed discussions on the above funding
opportunities and anticipates concluding this process in the near term. As
such, the Directors are therefore reasonably confident that the necessary
funding will be secured, as and when required, by executing on one of the
above options under consideration, such that the Directors have a reasonable
expectation that the Company will continue in operational existence for the
next 12 months.

Accordingly, the Directors believe that as at the date of this report it is
appropriate to continue to adopt the going concern basis in preparing the
financial statements.

 

Financial assets

 

Financial assets and financial liabilities are recognised when the Company
becomes a party to the contractual provisions of a financial instrument.
Financial assets and financial liabilities are offset if there is a legally
enforceable right to set off the recognised amounts and interests and it is
intended to settle on a net basis. Cash comprises cash in hand and on demand
deposits. Cash equivalents are short-term, highly liquid investments that are
readily convertible to known amounts of cash and that are subject to an
insignificant risk of changes in value with maturities of less than 90 days.

 

Financial liabilities

 

The Company does not currently have any financial liabilities measured at fair
value through profit or loss, therefore all financial liabilities are
initially measured at fair value, net of transaction costs, and are
subsequently measured at amortised cost. The Company recognises an equity
instrument on any contract that evidences a residual interest in the assets of
the Company. In this period Ordinary Shares were the only equity instrument,
recognised at the point at which a call is made on the Shareholders.

 

Earnings per Ordinary Share

 

The Company presents basic and diluted earnings per share data for its
Ordinary Shares. Basic earnings per Ordinary Share is calculated by dividing
the profit or loss attributable to Shareholders by the weighted average number
of Ordinary Shares outstanding during the period. Diluted earnings per
Ordinary Share is calculated by adjusting the earnings and number of Ordinary
Shares for the effects of dilutive potential Ordinary Shares.

 

 

3.    USE OF ASSUMPTIONS AND ESTIMATES

 

In preparing the Company Financial Information, the Directors have to make
judgments on how to apply the Company's accounting policies and make estimates
about the future. The Directors do not consider there to be any critical
judgments that have been made in arriving at the amounts recognised in the
Company Financial Information.

 

 

4.    DIRECTORS' EMOLUMENTS

 

 31 July 2024  Directors'  Consultancy  Social Security  Total

               fees        fees         £'000            £'000

               £'000       £'000
 P Atherley    26,075      53,500       3,120            82,695
 S Quinn       19,556      30,000       2,340            51,896
 H Pein        9,000       -            -                9,000
 V Jeckel      18,000      113,000      2,340            133,340
 Total         72,631      196,500      7,800            276,931

 

There were no staff costs other than directors fees as no staff were employed
by the Company during the or prior period.

 

 

5.    FINANCIAL RISK MANAGEMENT

The Company uses a limited number of financial instruments, comprising cash
and various items such as trade payables, which arise directly from
operations. The Company does not trade in financial instruments.

Financial risk factors

The Company's activities expose it to a variety of financial risks: credit
risk and liquidity risk. The Company's overall risk management programme
focuses on the unpredictability of financial markets and seeks to minimise
potential adverse effects on the Company's financial performance.

(a) Credit risk

The Company does not have any major concentrations of credit risk related to
any individual customer or counterparty.

(b) Liquidity risk

Prudent liquidity risk management implies maintaining sufficient cash, the
Company ensures it has adequate resource to discharge all its liabilities. The
directors have considered the liquidity risk as part of their going concern
assessment.

Fair values

Management assessed that the fair values of other receivables approximate
their carrying amounts largely due to the short-term maturities of these
instruments.

 

 

6.    CAPITAL MANAGEMENT POLICY

The Company's objectives when managing capital are to safeguard the Company's
ability to continue as a going concern in order to provide returns for
shareholders and benefits for other stakeholders and to maintain an optimal
capital structure to reduce the cost of capital. The capital structure of the
Company consists of equity attributable to equity holders of the Company,
comprising issued share capital and reserves.

 

7.    FINANCIAL INSTRUMENTS

The Company's principal financial instruments comprise other receivables. The
Company's accounting policy and method adopted, including the criteria for
recognition, the basis on which income and expenses are recognised in respect
of this financial asset. The Company does not use financial instruments for
speculative purposes.

 

There are no financial assets that are either past due or impaired.

 

 

8.    TRADE AND OTHER RECEIVABLES

 

                                    31 July  31 July

                                    2024     2023
                                    £        £
 Prepayments                        29,982   68,207
 VAT receivable                     65,193   97,117
 Other receivables                  2,574    226,974
 Total trade and other receivables  97,749   392,298

 

 

9.    EARNINGS PER SHARE

 

The loss per share has been calculated using the loss for the year and the
weighted average number of ordinary shares entitled to dividend rights which
were outstanding during the year. There were no potentially dilutive ordinary
shares at the year end.

 

                                                                    31 July     31 July

                                                                    2024        2023
                                                                    £           £
 Loss for the period attributable to equity holders of the Company

                                                                    (677,049)   (1,066,646)

 Weighted average number of ordinary shares (number of shares)

                                                                    8,814,851   7,199,998

 Loss per share (pence per share)

                                                                    (7.7)       (14.8)

 

 

 

10.  SHARE CAPITAL & RESERVES

 

 

                                Number of ordinary shares of 2p  Share Capital  Share premium  Shares to issue  Share based payments

                                                                 £              £              £                £
 At 31 January 2023             7,199,998                        144,000        2,413,243      -                63,221
 Shares to issue                -                                -              -              872,162          -
 Issue of Options and Warrants  -                                -              -              -                62,832
 At 31 July 2023                7,199,998                        144,000        2,413,243      872,162          126,053
 At 31 January 2024             8,814,851                        176,297        4,261,627      -                259,771
 Issue of Options and Warrants  -                                -              -              -                118,020
 At 31 January 2024             8,814,851                        176,297        4,261,627      -                337,791

 

 

 

On 31 May 2023 the Company entered into a loan arrangement with Paul Atherley
for £920,800 in gross funding (£872,162 net of costs) to be repaid in a
fixed number of ordinary shares in the Company, at a fixed price, at a future
date. Under IFRS, the terms of this loan required it to be recorded as an
equity reserve "shares to issue" as the economic risks of the instrument are
more closely aligned to equity than debt, with transactions costs being taken
as a deduction from this equity reserve.  As a consequence these net amounts
received as at the prior period reporting date were recognised in the "shares
to issue" reserve.  On issuance of the repayment shares, which took place on
5 October 2023, these amounts were reallocated to the share capital and share
premium reserves.

 

 

 

No further issues of Ordinary Shares were made during the period.

 

 

11.  TRADE AND OTHER PAYABLES

 

 

                                 31 July 2024  31 July

                                 £             2023

                                               £
 Trade payables                  697,574       1,011,480
 Other payables                  72,521        123,996
 Accrued expenses                331,902       187,972
 Total trade and other payables  1,101,997     1,323,448

 

 

12.  POST BALANCE SHEET EVENTS

 

On 5 August 2024, the Company granted 500,000 options to directors and
advisors as part of an incentivisation package linked to the achievement of
the securing funding to complete the FEED study for the Company's LHM
refinery.  The options have an exercise price of nil, expiry period of 5
years and become exercisable once the funding required for the completion of
the FEED study has been fully secured.

 

Details of the allocation of the above options are as follows:

 

 Receiving Party          Number of options

 Paul Atherley            150,000
 Sam Quinn                150,000
 Vikki Jeckell            150,000
 Helen Pein               25,000
 Consultants - non board  25,000

 Total                    500,000

 

 

13.  ULTIMATE CONTROLLING PARTY

 

As at 31 July 2024, the company has no ultimate controlling party.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR QFLFBZBLLFBK

Recent news on Alkemy Capital Investments

See all news